Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Biomed Res Int ; 2015: 282301, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26247014

RESUMO

OBJECTIVE: To compare pregnancy rate after controlled ovarian hyperstimulation and intrauterine insemination (COH-IUI) with no treatment in patients with endometriosis-associated infertility treated with laparoscopy. DESIGN: A clinical cohort study. SETTING: University-level tertiary care center. PATIENTS: 238 women with various stages of endometriosis after laparoscopic treatment. INTERVENTIONS: Either COH-IUI or follow-up for 12 months. MAIN OUTCOME MEASURES: The primary outcome measures were clinical pregnancy and live birth rate. Predictive factors evaluated were female age, maternal BMI, and duration of infertility. RESULTS: The pregnancy rate attained after the integrated laparoscopy-COH-IUI approach was 53.4%, while it was significantly lower (38.5%) in the control group. Similarly, a significant difference was observed in live births (48.3% versus 34.2%). Patients with severe endometriosis were less likely to achieve pregnancy (38%) and live birth (35%) than their counterparts with milder forms (57% and 53%). CONCLUSIONS: In patients with endometriosis-based infertility, surgery followed by COH-IUI is more effective than surgery alone.


Assuntos
Endometriose/epidemiologia , Endometriose/cirurgia , Infertilidade/prevenção & controle , Inseminação Artificial/estatística & dados numéricos , Indução da Ovulação/estatística & dados numéricos , Taxa de Gravidez , Adulto , Distribuição por Idade , Estudos de Coortes , Terapia Combinada/estatística & dados numéricos , Comorbidade , Feminino , Humanos , Hungria/epidemiologia , Infertilidade/epidemiologia , Laparoscopia/estatística & dados numéricos , Nascido Vivo/epidemiologia , Gravidez , Prevalência , Fatores de Risco , Resultado do Tratamento
2.
Fetal Pediatr Pathol ; 31(1): 55-9, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22764758

RESUMO

Sonographic scan revealed a homogenously hyperechogenic lesion in the right fetal lung with microcystic pattern by a primigravid women at 22nd weeks of gestation. A large congenital pulmonary airway malformation (CPAM) was suspected with a lesion-to-lung ratio over 90%. The microcystic image of this thoracic anomaly was moderately visible on magnetic resonance imaging (MRI) at that early stage of the pregnancy. Fetopsy confirmed the diagnosis as a pure microcystic CPAM following termination of pregnancy. A controlled prospective study could be performed to compare ultrasound as a diagnostic modality to the MRI, focusing on volumetry, signal characteristics, and follow-up/regression of fetal pulmonary malformations.


Assuntos
Malformação Adenomatoide Cística Congênita do Pulmão/diagnóstico , Imageamento por Ressonância Magnética/métodos , Ultrassonografia Pré-Natal/métodos , Feminino , Humanos , Gravidez , Diagnóstico Pré-Natal/métodos
3.
Hum Immunol ; 73(7): 726-31, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22548718

RESUMO

Of the systemic autoimmune diseases that lead to sterility/infertility, antiphospholipid syndrome (APS) has an outstanding importance; it may be associated with abortion and premature birth which are included in its diagnostic criteria, as well as preeclampsia, pregnancy-induced hypertension, foetal retardation, miscarriage, stillbirth and sterility. Between 2004 and 2009, on the Department of Immunology in the Zala County Hospital, 100 female patients with sterility (st)/infertility (if) (33/67), (mean age: 34.08 years) underwent, in addition to history taking and physical examination, an assessment by immune-serologic tests (ANA, anti-dsDNA, ENA-Profile, anti-TPO, a-sperm, aCL, aPS, aß2GP1, aANX, and aPT). Positive aCL on two occasions could be demonstrated in 27/100 cases (27%) (st/if: 7/20). Among them 4 cases of primary APS have been diagnosed respectively. In the remaining 17 patients the clinical picture did not fulfil criteria. In addition to the twofold positive aCL, unusual antiphospholipid antibodies including aß2GP1, aPS or both were present in 1/27, 2/27 and 1/27 patients, as well as aANX and aPT in 3/26 and 1/27 patients respectively. One-time positive aCL occurred in 16/100 women (16%) (st/if: 5/11); among them aPT and aß2GP1 could be detected in 1/16 patient each. Based on the clinical picture, we raised the possibility of primary APS in 2/16 patients. Among the aCL-negative women, we found the unusual antibodies of APS in 8/57 patients (14%) including positivity of aß2GP1, aPS, aPT and aANX in 4/57, 4/57, 2/57 and 3/57 patients respectively; taking the clinical criteria of APS into consideration, primary APS could be stated in 2/57 patients of them. The 32 pregnancies developed in the follow-up period upon administration of acetylsalicylic acid (ASA) and maintenance dose low molecular weight heparin (LMWH), together with prednisolone in patients with secondary APS, resulted in 23 deliveries and 5 miscarriages; 4 pregnancies are currently in progress. The results of our investigations highlight the significance of demonstrating latent autoimmune diseases in female patients with sterility/infertility, as barrenness can be terminated by the appropriate treatment of these conditions.


Assuntos
Síndrome Antifosfolipídica/diagnóstico , Infertilidade Feminina/diagnóstico , Adulto , Anticorpos Antifosfolipídeos/sangue , Síndrome Antifosfolipídica/complicações , Síndrome Antifosfolipídica/tratamento farmacológico , Aspirina/administração & dosagem , Aspirina/efeitos adversos , Feminino , Seguimentos , Heparina de Baixo Peso Molecular/administração & dosagem , Heparina de Baixo Peso Molecular/efeitos adversos , Humanos , Infertilidade Feminina/etiologia , Infertilidade Feminina/prevenção & controle , Prednisona/administração & dosagem , Prednisona/efeitos adversos , Gravidez , Resultado da Gravidez , Sorologia
4.
Orv Hetil ; 143(24): 1475-8, 2002 Jun 16.
Artigo em Húngaro | MEDLINE | ID: mdl-12138645

RESUMO

INTRODUCTION: Endometriosis is one of the most common gynaecological conditions in women of reproductive age. The aim of the authors' study was to compare the relative safety, efficacy and side effects of nafarelin and triptorelin. PATIENTS AND METHODS: They treated 133 patients for six months and followed up for at least an additional 6 months. In the diagnosis of the endometriosis they use the gold standard, the laparoscopy. RESULTS: During the 6-month therapy with analogues, there was a noticeable decline in the symptoms of the disease, there was no significant change in the efficacy and was no difference in main side effects of the two drugs. CONCLUSION: These treatments represent favourable approaches in the management of endometriosis.


Assuntos
Endometriose/tratamento farmacológico , Hormônio Liberador de Gonadotropina/análogos & derivados , Nafarelina/uso terapêutico , Pamoato de Triptorrelina/uso terapêutico , Adulto , Feminino , Seguimentos , Hormônios/uso terapêutico , Humanos , Pessoa de Meia-Idade , Nafarelina/efeitos adversos , Fatores de Tempo , Resultado do Tratamento , Pamoato de Triptorrelina/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...